315 related articles for article (PubMed ID: 25413668)
1. The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.
Witberg G; Lavi I; Assali A; Vaknin-Assa H; Lev E; Kornowski R
Catheter Cardiovasc Interv; 2015 Jul; 86(1):3-10. PubMed ID: 25413668
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.
Cho Y; Misumi T; Shimura S; Aki A; Furuya H; Odagiri S; Okada K; Ueda T
Eur J Cardiothorac Surg; 2014 Mar; 45(3):431-7. PubMed ID: 23979988
[TBL] [Abstract][Full Text] [Related]
4. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.
Capodanno D; Chisari A; Giacoppo D; Bonura S; Lavanco V; Capranzano P; Caggegi A; Ministeri M; Tamburino C
Catheter Cardiovasc Interv; 2013 Sep; 82(3):333-40. PubMed ID: 22936604
[TBL] [Abstract][Full Text] [Related]
5. Identify Unsuitable Patients with Left Main Coronary Artery Disease in Intermediate SYNTAX Scores Treated by Percutaneous Coronary Intervention.
Zhang C; Zheng Y; Liu X; Cheng Y; Liu Y; Yao Y; Wang X; Xu J
Heart Surg Forum; 2017 Dec; 20(6):E258-E262. PubMed ID: 29272225
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of Residual Coronary Stenoses After Functionally Complete Revascularization.
Kobayashi Y; Nam CW; Tonino PA; Kimura T; De Bruyne B; Pijls NH; Fearon WF;
J Am Coll Cardiol; 2016 Apr; 67(14):1701-11. PubMed ID: 27056776
[TBL] [Abstract][Full Text] [Related]
7. Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
Yan L; Li P; Wang Y; Han D; Li S; Zhang J; Jiang M; Fan L; Han Y; Cao F
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1(Suppl 1):606-615. PubMed ID: 31868307
[TBL] [Abstract][Full Text] [Related]
8. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
[TBL] [Abstract][Full Text] [Related]
9. Validation of the SYNTAX revascularization index to quantify reasonable level of incomplete revascularization after percutaneous coronary intervention.
Généreux P; Campos CM; Farooq V; Bourantas CV; Mohr FW; Colombo A; Morel MA; Feldman TE; Holmes DR; Mack MJ; Morice MC; Kappetein AP; Palmerini T; Stone GW; Serruys PW
Am J Cardiol; 2015 Jul; 116(2):174-86. PubMed ID: 25983123
[TBL] [Abstract][Full Text] [Related]
10. The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.
Park KW; Kang J; Kang SH; Ahn HS; Kang HJ; Koo BK; Chae IH; Youn TJ; Oh BH; Park YB; Kandzari D; Kim HS
Am Heart J; 2014 Mar; 167(3):384-392.e5. PubMed ID: 24576524
[TBL] [Abstract][Full Text] [Related]
11. Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index.
Généreux P; Campos CM; Yadav M; Palmerini T; Caixeta A; Xu K; Francese DP; Dangas GD; Mehran R; Leon MB; Serruys PW; Stone GW
EuroIntervention; 2015 Oct; 11(6):634-42. PubMed ID: 25308300
[TBL] [Abstract][Full Text] [Related]
12. Objectifying the level of incomplete revascularization by the residual SYNTAX score and evaluating its impact on the one-year outcome of percutaneous coronary intervention in patients with multi-vessel disease.
Alidoosti M; Saroukhani S; Lotfi-Tokaldany M; Jalali A; Sobh-Rakhshankhah A
Cardiovasc Revasc Med; 2016; 17(5):308-12. PubMed ID: 27198530
[TBL] [Abstract][Full Text] [Related]
13. Impact of the Residual SYNTAX Score on Outcomes of Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease.
Loutfi M; Ayad S; Sobhy M
Clin Med Insights Cardiol; 2016; 10():29-35. PubMed ID: 26997875
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of residual SYNTAX score in patients with ST-elevation myocardial infarction and multivessel disease: Analysis of an 8-year all-comers registry.
Braga CG; Cid-Alvarez AB; Diéguez AR; Alvarez BA; Otero DL; Sánchez RO; Pena XS; Salvado VG; Trillo-Nouche R; González-Juanatey JR
Int J Cardiol; 2017 Sep; 243():21-26. PubMed ID: 28532984
[TBL] [Abstract][Full Text] [Related]
15. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of patients with complex coronary artery disease according to agreement between the SYNTAX score and revascularization procedure in contemporary practice.
Witberg G; Lavi I; Gonen O; Assali A; Vaknin-Assa H; Lev E; Kornowski R
Coron Artery Dis; 2014 Jun; 25(4):296-303. PubMed ID: 24667126
[TBL] [Abstract][Full Text] [Related]
17. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
Puskas JD; Halkos ME; DeRose JJ; Bagiella E; Miller MA; Overbey J; Bonatti J; Srinivas VS; Vesely M; Sutter F; Lynch J; Kirkwood K; Shapiro TA; Boudoulas KD; Crestanello J; Gehrig T; Smith P; Ragosta M; Hoff SJ; Zhao D; Gelijns AC; Szeto WY; Weisz G; Argenziano M; Vassiliades T; Liberman H; Matthai W; Ascheim DD
J Am Coll Cardiol; 2016 Jul; 68(4):356-65. PubMed ID: 27443431
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of residual SYNTAX score after percutaneous coronary intervention in patients with chronic total occlusion and multivessel coronary artery disease: a comparison with coronary artery bypass grafting.
Jang WJ; Yang JH; Song YB; Hahn JY; Choi JH; Chun WJ; Oh JH; Park YH; Kim WS; Lee YT; Gwon HC; Choi SH
EuroIntervention; 2017 May; 13(1):97-105. PubMed ID: 28242583
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention.
Khan R; Al-Hawwas M; Hatem R; Azzalini L; Fortier A; Joliecoeur EM; Tanguay JF; Lavoie-L'Allier P; Ly HQ
Catheter Cardiovasc Interv; 2016 Nov; 88(5):740-747. PubMed ID: 26833916
[TBL] [Abstract][Full Text] [Related]
20. The impact of coronary artery disease severity on long-term outcomes in unprotected left main coronary artery revascularization.
Kahraman S; Zencirkiran Agus H; Demirci G; Can C; Demir AR; Güner A; Kalkan AK; Uzun F; Ertürk M; Yıldız M
Turk Kardiyol Dern Ars; 2021 Jan; 49(1):8-21. PubMed ID: 33390575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
